Overall survival in elderly mCRPC patients treated with Radium-223: a national multicenter study

被引：0
|
作者：
Lavelli, V. [1 ]
Cosma, L. [2 ]
Monari, F. [3 ]
Mascia, M. [4 ]
Costa, R. [5 ]
Rubini, G. [1 ]
Spanu, A. [6 ]
Farcomeni, A. [7 ]
Rizzini, E. Lodi [8 ]
Cindolo, L. [9 ]
Murabito, A. [5 ]
Nuvoli, S. [6 ]
Frantellizzi, V. [2 ]
Dionisi, V. [3 ]
Nappi, A. [1 ]
De Vincentis, G. [2 ]
机构：
[1] Univ Bari Aldo Moro, Dept Nucl Med, Bari, Italy
[2] Sapienza Univ Rome, Dept Radiol Sci Oncol & Anat Pathol, Rome, Italy
[3] St Orsola Marcello Malpighi Hosp, Radiat Oncol Ctr, Bologna, Italy
[4] Spirito Santo Hosp, Nucl Med Unit, Pescara, Italy
[5] Univ Palermo, Biomed Dept Internal & Specialist Med, Nucl Med Unit, Palermo, Italy
[6] Univ Sassari, Dept Med Surg & Expt Sci, Unit Nucl Med, Sassari, Italy
[7] Univ Roma Tor Vergata, Dept Econ & Finance, Rome, Italy
[8] St Orsola Marcello Malpighi Hosp, Nucl Med Unit, Bologna, Italy
[9] Villa Stuart Private Hosp, Dept Urol, Rome, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-857
引用
收藏
页码：S423 / S423
页数：1
相关论文
共 50 条
  • [1] A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223
    Frantellizzi, Viviana
    Monari, Fabio
    Mascia, Manlio
    Costa, Renato
    Rubini, Giuseppe
    Spanu, Angela
    Farcomeni, Alessio
    Rizzini, Elisa Lodi
    Cindolo, Luca
    Murabito, Alessandra
    Lavelli, Valentina
    Nuvoli, Susanna
    Cosma, Laura
    Dionisi, Valeria
    Nappi, Anna Giulia
    Andreola, Marco
    De Vincentis, Giuseppe
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (03) : 651 - 658
  • [2] A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223
    Viviana Frantellizzi
    Fabio Monari
    Manlio Mascia
    Renato Costa
    Giuseppe Rubini
    Angela Spanu
    Alessio Farcomeni
    Elisa Lodi Rizzini
    Luca Cindolo
    Alessandra Murabito
    Valentina Lavelli
    Susanna Nuvoli
    Laura Cosma
    Valeria Dionisi
    Anna Giulia Nappi
    Marco Andreola
    Giuseppe De Vincentis
    [J]. Aging Clinical and Experimental Research, 2021, 33 : 651 - 658
  • [3] Fracture Rate and Overall Survival in mCRPC Patients Treated with Radium-223 and Concomitant Abiraterone
    Schiff, J.
    Ledet, E.
    Cotogno, P. M.
    Sartor, O.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E140 - E141
  • [4] Overall survival in mCPRC patients treated with Radium-223 in association with bone health agents: a national multicenter study
    Frantellizzi, Viviana
    Monari, Fabio
    Mascia, Manlio
    Costa, Renato
    Rubini, Giuseppe
    Spanu, Angela
    Farcomeni, Alessio
    Rizzini, Elisa Lodi
    Cindolo, Luca
    Licari, Maria
    Lavelli, Valentina
    Nuvoli, Susanna
    Ricci, Maria
    Dionisi, Valeria
    Nappi, Anna Giulia
    De Vincentis, Giuseppe
    [J]. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2020, 96 (12) : 1608 - 1613
  • [5] Clinical aspects of mCRPC management in patients treated with radium-223
    Rizzini, Elisa Lodi
    Dionisi, Valeria
    Ghedini, Pietro
    Morganti, Alessio Giuseppe
    Fanti, Stefano
    Monari, Fabio
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [6] Clinical aspects of mCRPC management in patients treated with radium-223
    Elisa Lodi Rizzini
    Valeria Dionisi
    Pietro Ghedini
    Alessio Giuseppe Morganti
    Stefano Fanti
    Fabio Monari
    [J]. Scientific Reports, 10
  • [7] Primary Radical Prostatectomy or Ablative Radiotherapy as Protective Factors for Patients With mCRPC Treated With Radium-223 Dichloride: An Italian Multicenter Study
    Frantellizzi, Viviana
    Costa, Renato
    Mascia, Manlio
    Spanu, Angela
    Farcomeni, Alessio
    Licari, Maria
    Cindolo, Luca
    Nuvoli, Susanna
    Pontico, Mariano
    De Vincentis, Giuseppe
    [J]. CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : 185 - 191
  • [8] A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary
    Kuronya, Zs
    Sinkovics, I.
    Agoston, P.
    Biro, K.
    Bodrogi, I.
    Bode, I.
    Dank, M.
    Gyergyay, F.
    Vajdics, T.
    Kolonics, Zs
    Nagyivanyi, K.
    Ruzsa, A.
    Geczi, L.
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (04) : 777 - 783
  • [9] Alkaline phosphatase (ALP) decline and overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) in the REASSURE study.
    James, Nicholas D.
    Heinrich, Daniel
    Castro, Elena
    George, Saby
    Song, Daniel Y.
    Dizdarevic, Sabina
    Baldari, Sergio
    Essler, Markus
    De Jong, Igle Jan
    Lastoria, Secondo
    Hammerer, Peter G.
    Meltzer, Jeffrey
    Sandstrom, Per
    Verholen, Frank
    Tombal, Bertrand F.
    O'Sullivan, Joe M.
    Sartor, A. Oliver
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
    Vidal, Monica
    Delgado, Alejandro
    Martinez, Carlos
    Jaime Correa, Jose
    Cristina Durango, Isabel
    [J]. INTERNATIONAL BRAZ J UROL, 2020, 46 (04): : 599 - 611
12345